Landos Biopharma, Inc.

Landos Biopharma, Inc.verified

LABP

Price:

$22.93

Market Cap:

$71.68M

Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic candidate that targets lanthionine synthetase C-like protein 2 (LANCL2) for the treatment of ulcerative colitis (UC), Crohn's disease (CD), and eosinophilic esophagitis; NX-13, a gut-restricted oral therapeutic that targets NOD-like receptor X1 (NOD-like), a mitochondria-associated receptor associated with the modulation of inflammatory cytokines for UC and CD; and LABP-104, an orally-active and systemically bioavailable small molecule therape...[Read more]

Industry

Biotechnology

IPO Date

2021-02-04

Stock Exchange

NASDAQ

Ticker

LABP

The Enterprise Value as of November 2024 (TTM) for Landos Biopharma, Inc. (LABP) is 42.62M

According to Landos Biopharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 42.62M. This represents a change of 215.92% compared to the average of 13.49M of the last 4 quarters.

Landos Biopharma, Inc. (LABP) Historical Enterprise Value (quarterly & annually)

How has LABP Enterprise Value performed in the past?

The mean historical Enterprise Value of Landos Biopharma, Inc. over the last ten years is 230.18M. The current 42.62M Enterprise Value has changed 1.75% with respect to the historical average. Over the past ten years (40 quarters), LABP's Enterprise Value was at its highest in in the September 2021 quarter at 565.55M. The Enterprise Value was at its lowest in in the March 2023 quarter at -25920985.66.

Quarterly (TTM)
Annual

Average

230.18M

Median

230.90M

Minimum

-16512555.00

Maximum

479.00M

Landos Biopharma, Inc. (LABP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Landos Biopharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 70.25%

Maximum Annual Enterprise Value = 479.00M

Minimum Annual Increase = -108.93%

Minimum Annual Enterprise Value = -16512555.00

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023-14579367.04-11.71%
2022-16512555.00-108.93%
2021184.92M-61.39%
2020479.00M1.61%
2019471.40M70.25%

Landos Biopharma, Inc. (LABP) Average Enterprise Value

How has LABP Enterprise Value performed in the past?

The current Enterprise Value of Landos Biopharma, Inc. (LABP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

51.28M

5-year avg

220.84M

10-year avg

230.18M

Landos Biopharma, Inc. (LABP) Enterprise Value vs. Peers

How is LABP’s Enterprise Value compared to its peers?

Landos Biopharma, Inc.’s Enterprise Value is greater than eFFECTOR Therapeutics, Inc. (4.74M), greater than Apexigen, Inc. (-5121682.00), greater than Navidea Biopharmaceuticals, Inc. (-2504975.00), greater than Angion Biomedica Corp. (22.43M), less than Oncorus, Inc. (0), less than Apollomics, Inc. (42.71M), greater than Cardio Diagnostics Holdings, Inc. (-11494787.00), greater than TransCode Therapeutics, Inc. (9.47M), greater than NexImmune, Inc. (4.92M), greater than Xenetic Biosciences, Inc. (-1935978.00), greater than null (-509075.00),

Build a custom stock screener for Landos Biopharma, Inc. (LABP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Landos Biopharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Landos Biopharma, Inc. (LABP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Landos Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Landos Biopharma, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Landos Biopharma, Inc. (LABP)?

What is the 3-year average Enterprise Value for Landos Biopharma, Inc. (LABP)?

What is the 5-year average Enterprise Value for Landos Biopharma, Inc. (LABP)?

How does the current Enterprise Value for Landos Biopharma, Inc. (LABP) compare to its historical average?